Benitec Biopharma presents at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City Sep 11, 2017 | Press Release Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) announced that Chief Scientific Officer, David Suhy will be presenting today at the Rodman & Renshaw Global Investment Conference in New York City
